Tuncel v. Eli Lilly | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Tuncel v. Eli Lilly

Sort by

Viewing results 1‒7 of 7

FirstFT
FirstFT: Today’s top stories
...India, which passed 5m cases, will buy 100m doses of Russia’s Sputnik-V vaccine candidate. Eli Lilly’s antibody treatment reduced hospitalisations....
September 17, 2020
Companies
Prospering in the pandemic: 2020’s top 100 companies
...It has also signed deals with Vir Biotechnology to produce Covid-19 antibody products and with Eli Lilly and AstraZeneca to produce Covid-19 treatments. Song Jung-a 74....
January 1, 2021
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
News in-depthFT Alphaville
Of Trump, taxes, and earnings growth
...In sifting through the S&P 500, it has chosen to only include companies with 0-45 per cent tax rates, so as to eliminate bizarre outliers such as pharmaceutical company Eli Lilly, who reported a tax rate...
September 4, 2018
Health
FT Health: Is there a doctor on board?
...The government has vowed to tackle the price of cancer medicines, threatening revenues for multinationals such as Eli Lilly, Roche and Novartis....
July 13, 2018
Health
FT Health: Stem cells — pushing the boundaries
...Rival Eli Lilly announced job cuts and a focus on new medicines while AstraZeneca was boosted by good news on its cancer pipeline....
September 8, 2017
Due Diligence
Davos in the desert: Dispatch from Riyadh Premium content
...Lilly mulls spin-off or sale of animal health business (FastFT) Cargill ramps up animal nutrition business with Diamond V deal (FastFT) Asian buyers tap into ‘pampered pooch’ market (FT) ICE to buy bond...
October 25, 2017
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Inside BusinessRichard Waters
Tech industry has opened a Pandora’s box of patent strife
...But a wide coalition of other interests has now come out strongly against the proposed law: they include pharmaceuticals companies such as Eli Lilly and technology companies like Qualcomm, along with 3M...
April 3, 2014

Previous pagePage 1 of 1Next page